Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Neogenomics Inc (NQ: NEO)
33.88 USD  +0.62 (+1.86%)
Official Closing Price  /  Updated: 5:59 PM EDT, Jul 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,353,400
Open 33.40
Bid (Size) 33.00 (2)
Ask (Size) 34.78 (10)
Prev. Close 33.26
Today's Range 33.14 - 34.29
52wk Range 18.52 - 34.97
Shares Outstanding 80,617,016
Dividend Yield N/A
Performance
YTD
+16.63%
+16.63%
1 Month
+23.11%
+23.11%
3 Month
+29.31%
+29.31%
6 Month
+15.36%
+15.36%
1 Year
+45.53%
+45.53%
Top News
More News
NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020
from ACCESSWIRE
US Commercial Launch of InVisionFirst®-Lung
from GlobeNewswire News Releases
More News
Read More
NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients
from ACCESSWIRE
Annual results for the year ended 31 March 2020
from GlobeNewswire News Releases
NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference
from ACCESSWIRE
NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference
from ACCESSWIRE
Inivata Announces Strategic Collaboration and Investment from NeoGenomics
from GlobeNewswire News Releases
NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test
from ACCESSWIRE
NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference
from ACCESSWIRE
NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients
from ACCESSWIRE
NeoGenomics Shows Market Leadership With Jump To 81 RS Rating
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.